Spatial genomics maps the structure, nature and evolution of cancer clones

Artem Lomakin(European Bioinformatics Institute), Jessica Svedlund(Stockholm University), Carina Strell(Uppsala University), Milana Gatarić(European Bioinformatics Institute), Artem Shmatko(German Cancer Research Center), Gleb D. Rukhovich(German Cancer Research Center), Jun Sung Park(European Bioinformatics Institute), Young Seok Ju(Korea Advanced Institute of Science and Technology), Stefan C. Dentro(European Bioinformatics Institute), Vitalii Kleshchevnikov(Wellcome Sanger Institute), Vasyl Vaskivskyi(Wellcome Sanger Institute), Tong Li(Wellcome Sanger Institute), Omer Ali Bayraktar(Wellcome Sanger Institute), Sarah E. Pinder(Guy's Hospital), Andrea L. Richardson(Johns Hopkins Hospital), Sandro Santagata(Brigham and Women's Hospital), Peter J. Campbell(Wellcome Sanger Institute), Hege G. Russnes(Oslo University Hospital), Moritz Gerstung(European Bioinformatics Institute), Mats Nilsson(Stockholm University), Lucy Yates(Wellcome Sanger Institute)
Nature
November 9, 2022
Cited by 173Open Access
Full Text

Abstract

Abstract Genome sequencing of cancers often reveals mosaics of different subclones present in the same tumour 1–3 . Although these are believed to arise according to the principles of somatic evolution, the exact spatial growth patterns and underlying mechanisms remain elusive 4,5 . Here, to address this need, we developed a workflow that generates detailed quantitative maps of genetic subclone composition across whole-tumour sections. These provide the basis for studying clonal growth patterns, and the histological characteristics, microanatomy and microenvironmental composition of each clone. The approach rests on whole-genome sequencing, followed by highly multiplexed base-specific in situ sequencing, single-cell resolved transcriptomics and dedicated algorithms to link these layers. Applying the base-specific in situ sequencing workflow to eight tissue sections from two multifocal primary breast cancers revealed intricate subclonal growth patterns that were validated by microdissection. In a case of ductal carcinoma in situ, polyclonal neoplastic expansions occurred at the macroscopic scale but segregated within microanatomical structures. Across the stages of ductal carcinoma in situ, invasive cancer and lymph node metastasis, subclone territories are shown to exhibit distinct transcriptional and histological features and cellular microenvironments. These results provide examples of the benefits afforded by spatial genomics for deciphering the mechanisms underlying cancer evolution and microenvironmental ecology.


Related Papers

No related papers found

Powered by citation graph analysis